Barbara Ann Karmanos Cancer Institute

Physician specializes in microvascular free tissue transfer following head and neck surgical oncology procedures DETROIT, Oct. 22, 2024 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute welcomes Hassan Nasser, M.D., an otolaryngologist and surgical oncologist who specializes in head and neck cancers. Dr. Nasser is part of the Head and Neck Oncology Multidisciplinary Team (MDT) at Karmanos and is now accepting new patients at the Karmanos Cancer Center in Detroit and Karmanos Cancer Institute – Roseville. He joined Karmanos on May 1, 2024. Continue Reading Hassan Nasser, M.D., has joined the Barbara Ann Karmanos Cancer Institute's Head and Neck Oncology Multidisciplinary Team. "One of the qualities that drove me toward the Head and Neck MDT and Karmanos is the team that has developed at this organization. I understand and admire their passion for their patients, and I know they are physicians and researchers dedicated to finding better options for head and neck cancer patients," said Dr. Nasser. "The quality and intent of their work is outstanding. Joining with my colleagues will continue to drive me to be the best physician I can be to my patients and provide them the best care possible." Dr. Nasser is an ear, nose and throat (ENT) physician with a subspecialty in diagnosing and treating head and neck cancers. He provides surgical removal for benign and cancerous tumors of the head and neck, including the face, jaw, neck, nose and sinuses, parathyroid, parotid gland, throat, thyroid, tongue, and voice box. He has a particular interest in robotic surgery for throat cancer. In addition, he performs the full spectrum of plastic and reconstruction surgery of defects after these types of surgeries, including microvascular free tissue transfer (free flap surgery). "Hassan's skill and detailed care that he provides his patients is what our Head and Neck Oncology MDT leader was looking for to help round out our comprehensive team," expressed George Yoo, M.D., FACS, chief medical officer at Karmanos Cancer Hospital. "Head and neck cancers are sensitive to treat and to heal from after treatment because these areas are commonly what people see first. With Dr. Nasser's expertise, he'll provide his patients with curative treatment and help them learn to love their most sensitive areas with reconstruction. We were impressed by Dr. Nasser, and we're happy that he's joined our team." Dr. Nasser was born and raised in southeast Michigan and obtained his bachelor's degree in neuroscience at the University of Michigan. He was then awarded the William K. Brehm full tuition scholarship to attend the University of Michigan Medical School. Following medical school, he completed his internship and residency training in otolaryngology at the world-renowned UCLA Medical Center. Dr. Nasser returned to the University of Michigan for fellowship training in head and neck surgical oncology and microvascular reconstruction. Before joining Karmanos, Dr. Nasser was the attending surgeon at Lakeshore Ear, Nose and Throat Center in St. Clair Shores. He is a diplomate of the American Board of Otolaryngology-Head and Neck Surgery, a member of the American Head & Neck Society, and has authored multiple peer-reviewed articles, book chapters, abstracts, and presentations. View Dr. Nasser's physician profile here. To request an appointment, visit karmanos.org or call 1-800-KARMANOS. About the Barbara Ann Karmanos Cancer Institute Karmanos Cancer Institute is a leader in transformative cancer care, research and education through courage, commitment and compassion. The Karmanos vision is a world free of cancer. As part of McLaren Health Care, Karmanos is the largest provider of cancer care and research in Michigan. For more than 75 years, the administrative and research headquarters, along with the premier specialty cancer hospital, have been located in downtown Detroit. With 16 network sites, Karmanos delivers world-renowned care and access to clinical trials throughout Michigan and northern Ohio. The National Cancer Institute recognizes Karmanos as one of the best cancer centers in the nation with a comprehensive cancer center designation. Its academic partnership with the Wayne State University School of Medicine provides the framework for cancer research and education – defining new standards of care and improving survivorship. For more information, call 1-800-KARMANOS (800-527-6266) or visit . Follow Karmanos on Facebook, Twitter, LinkedIn and YouTube. SOURCE Karmanos Cancer Institute WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

The head and neck surgeon specialist is now seeing new patients DETROIT, Sept. 23, 2024 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute welcomes Nithin Peddireddy, M.D., a head and neck surgical oncologist specializing in benign and malignant head and neck neoplasms. These include mouth, jaw, and throat cancers, salivary gland masses, melanoma, and skin cancers of the face, neck and scalp. Dr. Peddireddy joins Karmanos's Head and Neck Oncology Multidisciplinary Team (MDT). He is accepting new patients at Karmanos Cancer Center in Detroit and Karmanos Cancer Institute at McLaren Flint. He joined Karmanos and McLaren Health Care on Aug. 19, 2024. Continue Reading Nithin Peddireddy, M.D., joins the Barbara Ann Karmanos Cancer Institute in Detroit and the Karmanos Cancer Institute at McLaren Flint. "It's such an honor to join an organization at the forefront of cancer treatment and development," said Dr. Peddireddy. "Being from the Greater Flint area, I am excited to be able to provide care for patients from my hometown and in Detroit. I'm ready to work with my patients and colleagues to provide the best care and options for removing head and neck masses and the reconstruction necessary afterward." Dr. Peddireddy is an ear, nose and throat (ENT) physician with a subspecialty in advanced head and neck surgery, including thyroid and parathyroid surgery, and comprehensive reconstruction utilizing rotational flaps and microvascular surgery with free flaps. He'll work alongside medical and radiation oncologists, dental oncologists, endocrinologists, pathologists, radiologists, speech-swallow therapists, and other surgical oncologists to create individualized and thorough treatment plans for each of his patient cases. "We continue to grow our expertise to offer patients across the state the best oncologic care," said George Yoo, M.D., FACS, chief medical officer at the Karmanos Cancer Hospital. "Dr. Peddireddy will work side by side with experienced oncologists and collaborate on complicated cases, where we work to give the patient the best outcome. Offering his services not only in Detroit but further into the Karmanos Cancer Network also gives more patients access to surgical treatment that may not be offered elsewhere." "We are continuing our commitment to bring highly-trained oncology specialists to the Karmanos Cancer Institute at McLaren Flint so patients do not have to travel far to get the care they need," said Chris Candela, McLaren Flint President and CEO. "It has added significance to see someone like Dr. Peddireddy return to his hometown to be a valuable resource for the communities we serve." Dr. Peddireddy finished his fellowship in head and neck surgical oncology and microvascular reconstruction at Case Western Reserve University in Cleveland, Ohio. He completed his residency in otolaryngology at the University of Michigan, received his doctorate of medicine at the University of Cincinnati, and completed his undergraduate education at the U-M. He has participated in grant-funded research, has clinical teaching experience, and has contributed to numerous published studies, articles, chapters, and abstracts. Dr. Peddireddy is also a member of the American Academy of Otolaryngology – Head and Neck Surgery. View Dr. Peddireddy's physician profile here. To request an appointment, visit karmanos.org or call 1-800-KARMANOS. About the Barbara Ann Karmanos Cancer Institute Karmanos Cancer Institute is a leader in transformative cancer care, research and education through courage, commitment and compassion. The Karmanos vision is a world free of cancer. As part of McLaren Health Care, Karmanos is the largest provider of cancer care and research in Michigan. For more than 75 years, the administrative and research headquarters, along with the premier specialty cancer hospital, have been located in downtown Detroit. With 16 network sites, Karmanos delivers world-renowned care and access to clinical trials throughout Michigan and northern Ohio. The National Cancer Institute recognizes Karmanos as one of the best cancer centers in the nation with a comprehensive cancer center designation. Its academic partnership with the Wayne State University School of Medicine provides the framework for cancer research and education – defining new standards of care and improving survivorship. For more information, call 1-800-KARMANOS (800-527-6266) or visit . Follow Karmanos on Facebook, Twitter, LinkedIn and YouTube. About McLaren Flint McLaren Flint is a 378-bed tertiary teaching hospital in Flint, Michigan, offering a full range of comprehensive and advanced services for residents in greater Genesee County. McLaren Flint is affiliated with Michigan State University (MSU) College of Human Medicine in its medical residency programs, including family practice, internal medicine, general surgery, and orthopedic surgery. McLaren Flint also maintains Fellowship programs in vascular surgery, health psychology, cardiology, and pulmonary and critical care in partnership with MSU. McLaren Flint is certified as a BCBSM Blue Distinction Center+ for Bariatric Surgery and Spine Surgery and has earned the Advanced Comprehensive Stroke Center Designation by the Joint Commission and 2024 Get with the Guidelines Gold Plus Award for Stroke Care from the American Heart Association. McLaren Flint is further designated a Breast Imaging Center of Excellence by the American College of Radiology and holds Laboratory Accreditation from the American College of Pathologists. The Karmanos Cancer Institute at McLaren Flint is accredited by the American College of Radiology Radiation Oncology Practice and Michigan Radiation Oncology Quality Consortium (MROQC) 2021 Gold. Learn more at mclaren.org/flint. About McLaren Health Care McLaren Health Care, headquartered in Grand Blanc, Michigan, is a $6.6 billion, fully integrated health care delivery system committed to quality, evidence-based patient care and cost efficiency. The McLaren system includes 13 hospitals in Michigan, ambulatory surgery centers, imaging centers, a 640-member employed primary and specialty care physician network, commercial and Medicaid HMOs covering more than 732,838 lives in Michigan and Indiana, home health, infusion and hospice providers, pharmacy services, a clinical laboratory network and a wholly owned medical malpractice insurance company. McLaren operates Michigan's largest network of cancer centers and providers, anchored by the Karmanos Cancer Institute, a National Cancer Institute-designated comprehensive cancer centers. McLaren has 28,000 full-, part-time and contracted employees and more than 113,000 network providers throughout Michigan, Indiana and Ohio. Learn more at mclaren.org. SOURCE Karmanos Cancer Institute WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

Special event at Comerica Park promotes prostate health and cancer awareness, celebrates prostate cancer survivors and honors the legacy of those who have fought courageously DETROIT, July 1, 2024 /PRNewswire/ -- Hundreds of prostate cancer survivors are expected to fill the stands at Comerica Park on Monday, July 8, when the Barbara Ann Karmanos Cancer Institute, in partnership with the Detroit Tigers and McLaren Health Care, the Tigers' official health care system, join forces to promote prostate cancer awareness. During the fourth annual Prostate Cancer Awareness Night, fans will have the opportunity to learn more about prostate cancer screenings, signs and symptoms as they cheer on the Detroit Tigers against the Cleveland Guardians. Prostate cancer survivors will be honored throughout the game, and a Karmanos prostate cancer patient will throw the ceremonial first pitch. Continue Reading Karmanos Cancer Institute's Prostate Cancer Awareness Night with the Detroit Tigers and McLaren Health Care, the official health care system of the Tigers, is Monday, July 8, 2024. Gates will open to Comerica Park at 5 p.m., with first pitch scheduled for 6:40 p.m. Spreading prostate cancer awareness, Comerica Park will be decorated with a blue theme. "Prostate cancer is a disease that we can screen for and monitor PSA levels so that we can treat it at an early stage," said Elisabeth Heath, M.D., FACP, medical oncologist, leader of the Genitourinary Oncology Multidisciplinary Team and the Hartman Endowed Chair for Prostate Cancer Research. "We want to remind men not just to make their annual doctor's appointment but to show up and talk to their provider about their risk of developing prostate cancer and the screening options available to them. Prostate cancer is curable when we find it early, so delaying present knowledge of your health does not benefit your health in the future." The night will be filled with information about prostate cancer and prevention methods. A special pre-game ceremony will honor nine prostate cancer survivors who received care at Karmanos locations throughout the Karmanos Cancer Network. Throughout the ballpark, Karmanos will provide information about the disease and the importance of screening and early detection. "When I have to give a prostate cancer diagnosis, I let my patients know it's okay. We're going to work together, manage this treatment plan and tackle it," shared Dr. Heath. "I am so excited to honor many of my patients at the game who have had to hear those words but are doing well in their treatment and survivorship. Join us at Comerica Park and help me celebrate them and your loved ones who have fought the disease." Tigers fans who purchase the special Prostate Cancer Awareness Night ticket package will receive a Tigers game ticket for July 8 and a "Strike Out Prostate Cancer" t-shirt with a $5 donation to support prostate cancer research at Karmanos. Fans may also donate an additional amount when purchasing tickets to the July 8 game through tigers.com/prostate. A portion of the proceeds from a special 50/50 ticket raffle will also be designated to support prostate cancer research at Karmanos. Additional opportunities to donate will be displayed at the Karmanos tables. Click here to purchase tickets. About Prostate Cancer Second to skin cancer, prostate cancer is the most common cancer in American people with a prostate, affecting roughly one in eight during their lifetime. In 2024, the American Cancer Society estimates that 299,010 men will be diagnosed with the disease. Though most men diagnosed with prostate cancer do not die – only 1 in 44 succumb to the disease – prostate cancer is the second leading cause of cancer death in American men. This disease is most curable in its early stages, making early detection key. Karmanos, McLaren and the Detroit Tigers encourage men to talk with a health care provider about the benefits and risks of prostate cancer screening through a Prostate Specific Antigen (PSA) blood test and a Digital Rectal Exam (DRE). People with a prostate should consider prostate screening at age 50 (age 45 for African Americans and age 40 for men at even higher risk) if they are at average risk for prostate cancer. Visit karmanos.org/prostatefacts for more information. At Karmanos, the Genitourinary Oncology (GU) Multidisciplinary Team includes surgical oncologists, medical oncologists, radiation oncologists, radiologists, pathologists, plastic surgeons, pharmacists, specialized nurse practitioners, dietitians, social workers, genetic counselors and patient navigators. The team specializes in and focuses on treating genitourinary cancers, including prostate cancer, and shares its collective expertise to create a customized treatment plan for each patient. If you are diagnosed with prostate cancer, a referral is not needed to make an appointment with one of the GU experts at Karmanos. To request an appointment, visit karmanos.org or call 1-800-KARMANOS. About the Barbara Ann Karmanos Cancer Institute Karmanos Cancer Institute is a leader in transformative cancer care, research and education through courage, commitment and compassion. The Karmanos vision is a world free of cancer. As part of McLaren Health Care, Karmanos is the largest provider of cancer care and research in Michigan. For more than 75 years, the administrative and research headquarters, along with the premier specialty cancer hospital, have been located in downtown Detroit. With 17 network sites, Karmanos delivers world-renowned care and access to clinical trials throughout Michigan and northern Ohio. The National Cancer Institute recognizes Karmanos as one of the best cancer centers in the nation with a comprehensive cancer center designation. Its academic partnership with the Wayne State University School of Medicine provides the framework for cancer research and education – defining new standards of care and improving survivorship. For more information, call 1-800-KARMANOS (800-527-6266) or visit karmanos.org. Follow Karmanos on Facebook, Twitter, LinkedIn and YouTube. About McLaren Health Care McLaren Health Care, headquartered in Grand Blanc, Michigan, is a $6.6 billion, fully integrated health care delivery system committed to quality, evidence-based patient care and cost efficiency. The McLaren system includes 13 hospitals in Michigan, ambulatory surgery centers, imaging centers, a 640-member employed primary and specialty care physician network, commercial and Medicaid HMOs covering more than 732,838 lives in Michigan and Indiana, home health, infusion and hospice providers, pharmacy services, a clinical laboratory network and a wholly owned medical malpractice insurance company. McLaren operates Michigan's largest network of cancer centers and providers, anchored by the Karmanos Cancer Institute, a National Cancer Institute-designated comprehensive cancer centers. McLaren has 28,000 full-, part-time and contracted employees and more than 113,000 network providers throughout Michigan, Indiana and Ohio. Learn more at mclaren.org. SOURCE Karmanos Cancer Institute